drugset / Trial / NCT00097422
OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety and perform preliminary clinical evaluation in patients with mild to moderate CDAD.
Timeline
- Start
- 2004-11-01
- Primary completion
- 2005-04-01
- Completion
- 2005-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fidaxomicin | Other / unclassified | 50 mg | Oral |
| Subject | Fidaxomicin | Other / unclassified | 100 mg | Oral |
| Subject | Fidaxomicin | Other / unclassified | 200 mg | Oral |